Literature DB >> 2989831

Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus.

T Folks, S Benn, A Rabson, T Theodore, M D Hoggan, M Martin, M Lightfoote, K Sell.   

Abstract

We have developed a continuous human T-cell line (A3.01) for the study of acquired immunodeficiency syndrome (AIDS)-associated retrovirus that mimics normal peripheral blood lymphocytes in susceptibility to viral cytopathic effect without the need for cell activation or conditioned medium. Following infection, substantial quantities of virus are produced during a 3- to 5-day period; the associated killing of cells can be monitored in a microtiter assay as a function of virus input. Southern blot hybridization of infected cellular DNAs indicated that no gross alteration occurred in the restriction maps of the proviral DNA during the transfer of virus to and its passage in A3.01 cells. This cell system offers an alternative to other AIDS retrovirus cell systems because it permits the monitoring of viral cytopathic effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989831      PMCID: PMC391138          DOI: 10.1073/pnas.82.13.4539

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

3.  Synthesis in vitro of keratin polypeptides directed by mRNA isolated from newborn and adult mouse epidermis.

Authors:  J Schweizer; K Goerttler
Journal:  Eur J Biochem       Date:  1980-11

4.  Identification of ecotropic proviral sequences in inbred mouse strains with a cloned subgenomic DNA fragment.

Authors:  H W Chan; T Bryan; J L Moore; S P Staal; W P Rowe; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

5.  5'-Terminal sequences of eucaryotic mRNA can be cloned with high efficiency.

Authors:  H Land; M Grez; H Hauser; W Lindenmaier; G Schütz
Journal:  Nucleic Acids Res       Date:  1981-05-25       Impact factor: 16.971

6.  RNA-directed DNA polymerase and virus-induced leukemia in mice.

Authors:  A M Wu; R C Ting; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

7.  Characterization of polyoma viral DNA sequences in polyoma-induced hamster tumor cell lines.

Authors:  M A Israel; D F Vanderryn; M L Meltzer; M A Martin
Journal:  J Biol Chem       Date:  1980-04-25       Impact factor: 5.157

8.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Authors:  M S Gottlieb; R Schroff; H M Schanker; J D Weisman; P T Fan; R A Wolf; A Saxon
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

9.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  144 in total

1.  Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.

Authors:  R E Kiernan; A Ono; E O Freed
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.

Authors:  F Clavel; J M Orenstein
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.

Authors:  R Shibata; M Kawamura; H Sakai; M Hayami; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types.

Authors:  E K Ross; A J Buckler-White; A B Rabson; G Englund; M A Martin
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

Authors:  M G Davis; S C Kenney; J Kamine; J S Pagano; E S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.

Authors:  C R Brown; M S Nakamura; J D Mosca; G S Hayward; S E Straus; L P Perera
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro.

Authors:  K A Qatsha; C Rudolph; D Marmé; C Schächtele; W S May
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

10.  Infection with human T-lymphotropic virus types I and II results in alterations of cellular receptors, including the up-modulation of T-cell counterreceptors CD40, CD54, and CD80 (B7-1).

Authors:  C S Dezzutti; D L Rudolph; R B Lal
Journal:  Clin Diagn Lab Immunol       Date:  1995-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.